Transforming growth factor-β1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. - Janssens,K.; ten Dijke,P.; Ralston,SH.; Bergmann,C.; Van Hul,W. (J Biol Chem, 2003)